Business Wire

Business Figures for the First Half of 2017: Sartorius Continues to Grow

Del

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1.

"Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the field of bioprocess data analytics, which our Bioprocess Solutions Division recently entered through an acquisition. For the second half, we expect a somewhat improved market environment in North America and confirm our sales and earnings forecast for both divisions and the Group."

Business development of the Sartorius Group

In the first half of 2017, sales revenue rose by 11.5% in constant currencies (reported: 12.6%) from 625.4 million euros to 704.1 million euros. The Asia/Pacific region recorded the highest gain, with sales up 34.8% to 172.2 million euros. In the EMEA2 and Americas regions, Sartorius sales grew by 5.9% to 302.9 million euros and by 4.8% to 229.0 million euros, respectively, against a high prior-year revenue base (all regional growth figures in constant currencies).

Earnings in the reporting period increased overproportionately again relative to sales. Underlying EBITDA thus rose 13.8%, primarily due to economies of scale, from 153.4 million euros to 174.5 million euros. The respective margin reached 24.8% relative to 24.5% a year ago. Relevant net profit3 for the Group increased 13.6% from 62.4 million euros to 70.9 million euros. This corresponds to earnings per ordinary share of 1.03 euros (H1 2016: 0.91 euros) and per preference share, 1.04 euros (H1 2016: 0.92 euros).

The company's key financial indicators remained at robust levels even after the most recent acquisitions of Essen BioScience in March 2017 and Umetrics in April 2017. At the end of the reporting period, the company's equity ratio was 32.6% and its ratio of net debt to underlying EBITDA stood at 2.7 (Dec. 31, 2016: 42.0%% and 1.5, resp.). At 12.9%, the capex ratio in the first half was within the range expected. Investment activities focused on expansion of the plant for manufacturing single-use bags and filters in Yauco, Puerto Rico, as well as on the combination and expansion of Group headquarters in Goettingen, Germany.

As of the reporting date on June 30, 2017, Sartorius employed 7,364 people total, 453 more than as of December 31, 2016 (around +7%).

Business development of the divisions

As expected, market growth for the bioprocess business normalized after 2015 and 2016, two years of extraordinarily strong expansion. Sales revenue of the Bioprocess Solutions Division, which focuses on single-use products for the manufacture of biopharmaceuticals, rose despite the high comparable base of the previous year, by 8.0% in constant currencies to 510.9 million euros (reported: +8.8%). In particular, development in the Americas was influenced by relatively soft customer demand and limited delivery capacity for cell culture media, while business in Asia grew very dynamically, especially due to relatively large equipment projects. Consolidation of kSep acquired in July 2016 and Umetrics purchased in April 2017 contributed close to one percentage point to growth. Underlying EBITDA for Bioprocess Solutions rose overproportionately with respect to sales, by 10.0% to 140.8 million euros. The division's corresponding margin was 27.6% relative to 27.3% in the prior-year period.

The Lab Products & Services Division, which offers laboratory instruments and technologies primarily for the pharma sector and public research, expanded very dynamically in the first six months. This was also due to its acquisition of cell analysis specialist Essen BioScience. Its sales thus rose 22.1% (reported: +24.1%) to 193.2 million euros. While organic growth was about 7%, acquisitions contributed around 15% to the division's revenue growth. Reporting a gain of 33.1%, Lab Products & Services significantly increased its underlying EBITDA overproportionately from 25.3 million euros to 33.7 million euros. Its corresponding margin was 17.5% relative to 16.3% in the previous period.

Forecast for the full year confirmed

Based on the company's first-half business performance, management confirms its forecast raised at the beginning of April for the full year. Management thus projects that Group sales revenue for the full year will grow by about 12% to 16% and the underlying EBITDA margin will increase slightly more than by half a percentage point over the prior-year figure of 25.0%. The capex ratio for the current fiscal year is projected to remain at around 12% to 15%.

Regarding the two divisions, management continues to anticipate that sales for Bioprocess Solutions will grow by about 9% to 13%, which includes a good one percentage point of non-organic growth to be contributed by the acquired companies kSep and Umetrics. With regard to delivery capacities for cell culture media, management assumes that this situation will normalize during the third quarter of the current year. The division's underlying EBITDA margin is projected to rise by about half a percentage point over the prior-year figure of 28.0%.

For the Lab Products & Services Division, Group management continues to project that, assuming an overall stable economic environment, sales will increase by about 20% to 24%. This includes non-organic growth of around 17 percentage points to be contributed by the companies acquired, IntelliCyt, ViroCyt and Essen BioScience. The division's underlying EBITDA margin is expected to rise by nearly two percentage points compared with the prior-year figure of 16.0%.

All forecasts are based on constant currencies.

1 Sartorius uses underlying EBITDA (earnings before interest, taxes, depreciation and amortization and adjusted for extraordinary items) as the key profitability indicator

2 EMEA = Europe | Middle East | Africa

3 After non-controlling interest, adjusted for extraordinary items and non-cash amortization, as well as based on the normalized financial result and corresponding tax effects

This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties. This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

Current image files

Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG

www.sartorius.com/fileadmin/media/global/company/Sartorius_Kreuzburg.jpg

Sartorius products used in the manufacture of medications

www.sartorius.com/mediafile/corp/Sartorius_0232_PG9_01_RGB.jpg

Sartorius products used in pharmaceutical research

www.sartorius.com/mediafile/corp/Sartorius_0424_PG14.jpg

Conference call

Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius, will discuss the company's results with analysts and investors on Friday, July 21, 2017, at 3:30 p.m. Central European Time (CET) in a teleconference. You may register by clicking on the following link:

http://services.choruscall.de/DiamondPassRegistration/register?confirmationNumber=8963117&linkSecurityString=256e3090d

Alternatively, you can dial into the teleconference, without registering, at:

+49 (0) 69 566 03 6000

His presentation will be available on July 21, 2017, starting at 3:15 p.m. CET, for viewing on our website at:

http://www.sartorius.com/com/group/investor-relations/sartorius-ag/

Upcoming financial dates

October 24, 2017 Publication of nine-month figures (January to September 2017)

A Profile of Sartorius

The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes. Founded in 1870, the company earned sales revenue of more than 1.3 billion euros in 2016. More than 6,900 people work at the Group's 50 manufacturing and sales sites, serving customers around the globe.

Key Figures for the First Half of 2017

  Sartorius Group   Bioprocess Solutions   Lab Products & Services
in millions of € (unless otherwise specified)   H1
2017
  H1
2016
 

Δ in
%
Reported

 

Δ in
% cc1

  H1
2017
  H1
2016
 

Δ in
%
Reported

 

Δ in
% cc1

  H1
2017
  H1
2016
 

Δ in
%
Reported

 

Δ in
% cc1

Sales Revenue and Order Intake
Sales revenue   704.1   625.4   12.6   11.5   510.9   469.8   8.8   8.0   193.2   155.7   24.1   22.1
- EMEA2   302.9   288.1   5.1   5.9   209.4   207.2   1.0   2.2   93.5   80.8   15.7   15.1
- Americas2   229.0   212.3   7.9   4.8   181.3   181.1   0.1   -2.6   47.7   31.2   53.0   47.5
- Asia | Pacific2   172.2   125.1   37.7   34.8   120.3   81.5   47.6   44.4   52.0   43.6   19.2   17.2
Order intake   741.9   677.6   9.5   8.4   546.9   519.2   5.3   4.4   195.0   158.4   23.1   21.1
Earnings
EBITDA3   174.5   153.4   13.8       140.8   128.1   10.0       33.7   25.3   33.1    
EBITDA margin3 in %   24.8   24.5           27.6   27.3           17.5   16.3        
Net profit for the period4   70.9   62.4   13.6                                    
Financial Data per Share
Earnings per ordinary share4 in €   1.03   0.91   13.7                                    
Earnings per preference share4 in €   1.04   0.92   13.6                                    

1 In constant currencies abbreviated as "cc"

2 Acc. to the customer's location
3 Underlying
4 After non-controlling interest, adjusted for extraordinary items and non-cash amortization, as well as based on the normalized financial result and corresponding tax effects.

Contact information

Sartorius
Petra Kirchhoff
Vice President of Corporate Communications and IR
+49 (0)551.308.1686
petra.kirchhoff@sartorius.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

CNIM Presents a Rapid Version of The LCAT® Shore-to-Shore Featuring Unique Operational Capabilities23.10.2018 15:45Pressemelding

The L-CAT® Shore-to-shore presented by CNIM at Euronaval 2018 delivers a major increase in performance for amphibious missions. The L-CAT® Shore-to-shore has been upgrated since its launch 2 years ago. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181023005869/en/ CNIM's amphibious craft, the L-CAT® Shore-to-shore (Photo: CNIM) The L-CAT® Shore-to-shore is now the only vessel with the ability to transport 80 tonnes at 25 knots in conditions up to sea state 5, land in shallow water (~1m) and accommodate 42 passengers for long distance trips. Highly maneuvrable, the L-CAT® Shore-to-shore provides exceptional operational flexibility for amphibious assaults and humanitarian operations, without compromising between speed and payload. Its wide loading platform (145 m²), ability to travel up to 800 nautical miles when loaded, self-defence and communication capabilities are tactical advantages for the projection of Forces. Its spee

Exterior Plus, a Portfolio Company of H.I.G. Capital, Acquires Impactmedia23.10.2018 13:03Pressemelding

Exterior Plus, the out-of-home advertising platform of H.I.G. Capital, announces the acquisition of Impactmedia (the “Company”), a leading shopping mall advertising company, with over 630 million viewers in high-traffic premium locations throughout Spain. This is a major step forward in Exterior Plus’s consolidation strategy, as it aims to become the Spanish leader in out-of-home advertising with a unique, diversified and highly-competitive product portfolio, reaching very diverse audiences at a national level. Impactmedia is an experienced leader in shopping mall advertising, offering digital advertising as well as special marketing actions. The Company operates in over 90 shopping centers where it has more than 1,200 digital displays. The acquisition allows Exterior Plus to gain a strong presence near points of sale, a key value driver for advertisers. H.I.G. Capital acquired and established the Exterior Plus group in December 2015. The group currently markets more than 25,000 advert

Active-Semi’s New PMICs Reduce Size and Increase Power Density with Leading Field Programable Technology23.10.2018 13:00Pressemelding

The ACT88325 and ACT88326 PMICs are integrated field programmable ActivePMU™ power management units, also referred to as PMICs (Power Management ICs). The products are highly flexible with non-volatile memory and come pre-programmed and can be field programmed via I²C or via GPIOs for multiple applications. The ACT88325 powers up based on the preconfigured startup sequence as soon as power is applied to the input pin, whereas ACT88326 implements a Push Button Startup that relies on a customer’s interaction with, for example, a portable application like an Action Camera, Video Doorbell, Body Camera or other handheld applications. “Low external component count, extremely small WLCSP package and high configurability significantly speeds time to market and reduces PCB size and BOM cost,” says David Briggs, VP and General Manager of Power Solutions at Active-Semi. “The ACT88325 and ACT88326 are a great addition to our lineup and are specifically designed for the highest power density in SSD

Visa Brings a Simpler, Safer Experience to Digital Payments23.10.2018 13:00Pressemelding

Visa (NYSE: V) today announced a continued commitment to reducing friction and improving security in digital commerce by reiterating support of the draft EMV® Secure Remote Commerce (SRC) Specification. The draft EMV SRC Specification provides a foundation for digital transactions that gives consumers, merchants and issuers a single digital point-of-sale, resulting in a consistent, convenient and secure way to pay. EMVCo has spent the last year gathering feedback from across the payment ecosystem on the specification. Visa now encourages merchants, issuers, acquirer gateways and other interested participants to provide feedback and comment during a 45-day public comment window. Once complete, EMVCo will publish the final specification. Shoppers are increasingly migrating to websites, mobile phones and voice-activated devices, but their buying experiences are full of friction because they are required to manually enter payment details. With SRC, consumers’ digital buying experiences wil

New Nordson EFD Fluid Dispensing Video Gallery is Now Live23.10.2018 12:23Pressemelding

Nordson EFD , a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, announces the launch of a new online video portal, which is now live and can be viewed at videos.nordsonefd.com. The portal can also be accessed through Nordson EFD’s existing Video Gallery web page at nordsonefd.com/videos. EFD strives to satisfy its customer base and wanted to create a more efficient and user-friendly video interface. The video gallery is organized with all videos on one main page so users do not have to search through different web pages to find what they need. “Generating product and application knowledge through video is important to EFD and users should receive the best experience possible,” said Rhonda Mitchell, Global Marketing Communications Manager at Nordson EFD. EFD’s new video gallery provides more than 200 videos in English and nine other languages. The gallery is organized by categories that are divided into subcategories, which makes loca

PotNetwork Holdings, Inc. Reports $18.1 Million in Sales Surpassing Entire Revenue Generated in 201723.10.2018 12:00Pressemelding

PotNetwork Holdings, Inc. (OTC Pink: POTN ) today announced sales of $18.1 Million for the first 9 months of the year, realizing an $8.6 Million increase in year over year sales. This follows the Company’s recent announcement of its record third quarter revenues of $6.1 Million. Driven by the growth of its wholly-owned subsidiary, Diamond CBD, Inc., PotNetwork Holdings, Inc. has taken root as an industry leader in the growing market for premium hemp extracts. PotNetwork Holdings is expanding its research and development, multinational marketing and international distribution of a broad range of hemp-derived cannabinoids and other natural hemp derivatives. PotNetwork Holdings also reported that sales of Diamond CBD Products are coming 60% from its wholesale distribution network and 40% from online sales including from www.diamondcbd.com. “I am extremely pleased with our year-over-year growth,” said Kevin Hagen, president of Diamond CBD. “We provide customers with a high-quality product